Updates are available Correction dated 2021-11-24
Click to view Correction: https://doi.org/10.1245/s10434-021-11006-w
-
Authors
Tillmann, Bourke W. https://orcid.org/0000-0002-7815-5972
Hallet, Julie
Guttman, Matthew P.
Coburn, Natalie
Chesney, Tyler
Zuckerman, Jesse
Mahar, Alyson
Zuk, Victoria
Chan, Wing C.
Haas, Barbara
,
Hsu, Amy
Manuel, Douglas
Wright, Frances
Gandell, Dov
Menjak, Ines
Gotlib-Conn, Lesley
Paladino, Grace
Galuzzo, Pietro
-
Funding
Funding for this research was provided by:
Sunnybrook AFP Innovation Fund
Ontario Institute for Cancer Research (P.HSR.156)
- License Information
-
More Information
Article History
Received: 19 March 2021
Accepted: 5 July 2021
First Online: 24 August 2021
Change Date: 24 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-021-11006-w
Declarations
:
: JH has received speaking honoraria from Ipsen Biopharmaceuticals Canada, Novartis Oncology, and Advanced Accelerator Applications. NC receives salary support from Cancer Care Ontario as Lead for Patient-Reported Outcomes, and an honorarium from Astra-Zeneca.
